Evidence map›Paper›PMID 37848760›Full record

ReviewMolecular biology reports2023

Kynurenine pathway and its role in neurologic, psychiatric, and inflammatory bowel diseases.

Mohammad Sheibani, Maryam Shayan, Mina Khalilzadeh, Zahra Ebrahim Soltani, Majid Jafari-Sabet, Mehdi Ghasemi, Ahmad Reza Dehpour

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular biology reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Mohammad Sheibani *Department of Pharmacology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Maryam Shayan *Experimental Medicine Research Centre, Tehran University of Medical Sciences, Tehran, MS, Iran.
Mina KhalilzadehExperimental Medicine Research Centre, Tehran University of Medical Sciences, Tehran, MS, Iran.
Zahra Ebrahim SoltaniExperimental Medicine Research Centre, Tehran University of Medical Sciences, Tehran, MS, Iran.
Majid Jafari-SabetDepartment of Pharmacology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Mehdi GhasemiDepartment of Neurology, Lahey Hospital and Medical Center, 41 Mall Road, Burlington, MA, 01803, USA. mehdi.ghasemi@lahey.org.ORCID http://orcid.org/0000-0002-1384-9826
Ahmad Reza DehpourExperimental Medicine Research Centre, Tehran University of Medical Sciences, Tehran, MS, Iran. dehpour@yahoo.com.
Tehran University of Medical Sciences · IRIran University of Medical Sciences · IRLahey Hospital and Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tryptophan metabolism along the kynurenine pathway is of central importance for the immune function. It prevents hyperinflammation and induces long-term immune tolerance. Accumulating evidence also demonstrates cytoprotective and immunomodulatory properties of kynurenine pathway in conditions affecting either central or peripheral nervous system as well as other conditions such as inflammatory bowel disease (IBD). Although multilevel association exists between the inflammatory bowel disease (IBD) and various neurologic (e.g., neurodegenerative) disorders, it is believed that the kynurenine pathway plays a pivotal role in the development of both IBD and neurodegenerative disorders. In this setting, there is strong evidence linking the gut-brain axis with intestinal dysfunctions including IBD which is consistent with the fact that the risk of neurodegenerative diseases is higher in IBD patients. This review aims to highlight the role of kynurenine metabolic pathway in various neurologic and psychiatric diseases as well as relationship between IBD and neurodegenerative disorders in the light of the kynurenine metabolic pathway.

Indexed as

Inflammatory Bowel DiseasesMental DisordersNeurodegenerative DiseasesHumansKynurenineMetabolic Networks and PathwaysKynurenineInflammatory bowel diseaseKynurenine pathwayNeurodegenrative diseasesNeurologyPsychiatryTryptophan

Identifiers

PMID37848760
OpenAlexW4387696611

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.